Loading…
Responsibly Addressing the Marijuana Policy Gap Act of 2017
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,805 other S bills in the 115th — cohort avg 41d
Responsibly Addressing the Marijuana Policy Gap Act of 2017 This bill amends various provisions of law and sets forth new provisions: to eliminate regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act for marijuana-related activities authorized by state or tribal law (i.e., state-authorized); to allow businesses that sell marijuana in compliance with state or tribal law to claim certain federal tax credits and deductions; to eliminate restrictions on print and broadcast advertising of state-authorized marijuana-related activities; to create protections for depository institutions that provide financial services to marijuana-related businesses; to specify that a marijuana-related business is entitled to federal bankruptcy protections; to establish a process to expunge criminal records related to certain marijuana-related convictions; to reestablish federal student aid eligibility for certain students convicted of a misdemeanor offense for marijuana possession; to exempt real property from civil forfeiture due to state-authorized marijuana-related conduct; to prohibit the inadmissibility or deportability of aliens for state-authorized marijuana-related conduct; to specify that drug-related criminal activity, which is prohibited in federally assisted housing, does not include state-authorized marijuana-related conduct; to establish a new, separate registration process to facilitate medical marijuana research; to authorize health care providers employed by the Department of Veterans Affairs to recommend participation in state marijuana programs; and to authorize medical providers through an Indian health program to make medical recommendations regarding marijuana.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2018 · fourth_quarter · Alcohol and Drug Abuse
H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation H.R. 3374 Drunk Driving H.R. 3534 State Legalized Marijuana S. 1553 Schedule 1 Controlled Substances S. 1554 Controlled Substance Continuing Education S. 1689 Controlled Substances Act H.R. 3964 Registration Requirements for Prescribers of Opioids H.R. 4482 Opioid Abuse and Addiction S. 2008 Opioid Epidemic and Drug Sample Backlogs H.R. 4903 Opioid Usage Reduction Best Practices Study H.R. 4922 Fentanyl Analogues H.R. 5109 Opioid Epidemic Distribution of Resources S. 2437 Opioid Grant Program S. 2440 Opioid Epidemic S. 2535 Opioid Quotas H.R. 5473 Alternative Methods for Data Collection H.R. 5581 Prescribers of Controlled Substances H.R. 5590 Medicare and Opioid Addictions H.R. 5723 Medicare Payment Advisory Commission H.R. 5782 Pharmaceutical Company Accountability S. 2680 Opioid Crisis S. 2691 Pharmaceutical Companies and Illegal Marketing S. 2729 Prevention of Prescription Opioid Misuse S. 2838 Reporting Information on Distribution of Opioids S. 2848 Controlled Substances and Alcohol Testing H.R. 6491 Reporting of Information on Distribution of Opioids H.R. 6608 Prescription Drug Monitoring Programs Data Collection H.R. 5812 Controlled Substance Overdose Prevention Activities
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $1,030,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Credit Union Administration (NCUA), Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2018 · third_quarter · Alcohol and Drug Abuse
H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation H.R. 3374 Drunk Driving H.R. 3534 State Legalized Marijuana S. 1553 Schedule 1 Controlled Substances S. 1554 Controlled Substance Continuing Education S. 1689 Controlled Substances Act H.R. 3964 Registration Requirements for Prescribers of Opioids H.R. 4482 Opioid Abuse and Addiction S. 2008 Opioid Epidemic and Drug Sample Backlogs H.R. 4903 Opioid Usage Reduction Best Practices Study H.R. 4922 Fentanyl Analogues H.R. 5109 Opioid Epidemic Distribution of Resources S. 2437 Opioid Grant Program S. 2440 Opioid Epidemic S. 2535 Opioid Quotas H.R. 5473 Alternative Methods for Data Collection H.R. 5581 Prescribers of Controlled Substances H.R. 5590 Medicare and Opioid Addictions H.R. 5723 Medicare Payment Advisory Commission H.R. 5782 Pharmaceutical Company Accountability S. 2680 Opioid Crisis S. 2691 Pharmaceutical Companies and Illegal Marketing S. 2729 Prevention of Prescription Opioid Misuse S. 2838 Reporting Information on Distribution of Opioids S. 2848 Controlled Substances and Alcohol Testing H.R. 6491 Reporting of Information on Distribution of Opioids H.R. 6608 Prescription Drug Monitoring Programs Data Collection H.R. 5812 Controlled Substance Overdose Prevention Activities
Client expense: $1,070,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2018 · second_quarter · Alcohol and Drug Abuse
H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation H.R. 3374 Drunk Driving H.R. 3534 State Legalized Marijuana S. 1553 Schedule 1 Controlled Substances S. 1554 Controlled Substance Continuing Education S. 1689 Controlled Substances Act H.R. 3964 Registration Requirements for Prescribers of Opioids H.R. 4482 Opioid Abuse and Addiction S. 2008 Opioid Epidemic and Drug Sample Backlogs H.R. 4903 Opioid Usage Reduction Best Practices Study H.R. 4922 Fentanyl Analogues H.R. 5109 Opioid Epidemic Distribution of Resources S. 2437 Opioid Grant Program S. 2440 Opioid Epidemic S. 2535 Opioid Quotas **Issues lobbied without specific bill number: Workers' Compensation Medicare Set-Aside H.R. 5473 Alternative Methods for Data Collection H.R. 5581 Prescribers of Controlled Substances H.R. 5590 Medicare and Opioid Addictions H.R. 5723 Medicare Payment Advisory Commission H.R. 5782 Pharmaceutical Company Accountability S. 2680 Opioid Crisis S. 2691 Pharmaceutical Companies and Illegal Marketing S. 2729 Prevention of Prescription Opioid Misuse S. 2838 Reporting Information on Distribution of Opioids S. 2848 Controlled Substances and Alcohol Testing
Client expense: $1,590,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
2018 · second_quarter · Medical/Disease Research/Clinical Labs
PROTECT AND EXPAND PATIENTS - including Veterans - Access to Medical Cannabis Since 2014, Congress has restricted the U.S. Department of Justice from spending appropriated funds that interfere with a states implementation of its legal Cannabis programs. This language remains the law today following passage of FY2018 Omnibus Appropriations Act. Further, the House Appropriations Committee recently voted to include language protecting medical Cannabis programs from federal interference within the base text of the FY2019 Commerce, Justice, Science and Related Agencies Appropriations Bill. Congress commitment to maintain this longstanding policy comports with the April 2018 poll by Quinnipiac University that found 70% of Americans oppose federal government interference in states that have enacted Cannabis programs. Americans do not think the federal government should try to prohibit the sale and use of Cannabis in the states where it has been legalized. Protecting access to Cannabis as medicine may also be an option as the country looks to address the opioid epidemic. Studies published in Health Affairs found that use of prescription opioids decreased in states with legal medical medical programs. Research into the potential benefits of medical Cannabis as an alternative to opiods - and other medications - is particularly critical for Americas veterans who often lack effective treatments for their complicated, service-related injuries and illnesses. The passage of H.R. 5520 - the VA Medicinal Cannabis Research Act of 2018 - in April 2018 authorized the Department of Veterans Affairs (VA) to advance scientific and medical research into the safety and efficacy of medical cannabis usage by veterans with diagnoses such as post-traumatic stress disorder (PTSD) and chronic pain. This is a critical step toward offering broader choices for treatment to service members, but it is only a first step. We need to continue to support not only the research of, but also the access to, medical Cannabis for veterans in an effort to provide them with the best care that this country can provide. Endorsed Legislation: Continuation of the Joyce | Leahy Amendment in the Appropriations Process H.R. 331 - States Medical Marijuana Property Rights Protection Act H.R. 1820 - Veterans Equal Access Act H.R. 2273 - Charlottes Web Medical Access Act of 2017 H.R. 2920/S.1374 - Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017 H.R. 1824/S. 780 - Responsibly Addressing the Marijuana Policy Gap Act of 2017 H.R. 5220 - The VA Medicinal Cannabis Research Act of 2018
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Taxation/Internal Revenue Code
H.R. 975 - Respect State Marijuana Laws Act of 2017 H.R. 1227 - Ending Federal Marijuana Prohibition Act of 2017 H.R. 1824/S. 780 - Responsibly Addressing the Marijuana Policy Gap Act of 2017 H.R. 2920/S.1374 - Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017 Continuation of the Joyce | Leahy Amendment in the Appropriations Process H.R. 331 - States Medical Marijuana Property Rights Protection Act H.R. 1820 - Veterans Equal Access Act H.R. 2273 - Charlottes Web Medical Access Act of 2017 H.R. 2920/S.1374 - Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017 H.R. 1824/S. 780 - Responsibly Addressing the Marij
Client expense: Not reported · Firm income: Not reported
2018 · second_quarter · Medical/Disease Research/Clinical Labs
H.R. 975 - Respect State Marijuana Laws Act of 2017 H.R. 1227 - Ending Federal Marijuana Prohibition Act of 2017 H.R. 1824/S. 780 - Responsibly Addressing the Marijuana Policy Gap Act of 2017 H.R. 2920/S.1374 - Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017 Continuation of the Joyce | Leahy Amendment in the Appropriations Process H.R. 331 - States Medical Marijuana Property Rights Protection Act H.R. 1820 - Veterans Equal Access Act H.R. 2273 - Charlottes Web Medical Access Act of 2017 H.R. 2920/S.1374 - Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017 H.R. 1824/S. 780 - Responsibly Addressing the Marij
Client expense: Not reported · Firm income: Not reported
2018 · second_quarter · Banking
H.R. 975 - Respect State Marijuana Laws Act of 2017 H.R. 1227 - Ending Federal Marijuana Prohibition Act of 2017 H.R. 1824/S. 780 - Responsibly Addressing the Marijuana Policy Gap Act of 2017 H.R. 2920/S.1374 - Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017 Continuation of the Joyce | Leahy Amendment in the Appropriations Process H.R. 331 - States Medical Marijuana Property Rights Protection Act H.R. 1820 - Veterans Equal Access Act H.R. 2273 - Charlottes Web Medical Access Act of 2017 H.R. 2920/S.1374 - Compassionate Access, Research Expansion, and Respect States (CARERS) Act of 2017 H.R. 1824/S. 780 - Responsibly Addressing the Marij
Client expense: Not reported · Firm income: Not reported
2018 · first_quarter · Alcohol and Drug Abuse
H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation H.R. 3374 Drunk Driving H.R. 3534 State Legalized Marijuana S. 1553 Schedule 1 Controlled Substances S. 1554 Controlled Substance Continuing Education S. 1689 Controlled Substances Act H.R. 3964 Registration Requirements for Prescribers of Opioids H.R. 4482 Opioid Abuse and Addiction S. 2008 Opioid Epidemic and Drug Sample Backlogs H.R. 4903 Opioid Usage Reduction Best Practices Study H.R. 4922 Fentanyl Analogues H.R. 5109 Opioid Epidemic Distribution of Resources S. 2437 Opioid Grant Program S. 2440 Opioid Epidemic S. 2535 Opioid Quotas **Issues lobbied without specific bill number: Workers' Compensation Medicare Set-Aside
Client expense: $1,220,000 · Firm income: Not reported
2017 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Funding for the State Criminal Alien Assistance Program (SCAAP); the Community Oriented Policing Services (COPS) program; and the Byrne/JAG program SCAAP Reauthorization (S 745) Cannabis Legislation (HR 331; HR 714; HR 715; 975; HR 1227; HR 1810; HR 1823; HR 1824; HR 1841; S 776; S 777; S 780)
Client expense: Not reported · Firm income: $20,000
Government targets: Army, Dept of (Corps of Engineers), Bureau of Justice Assistance, Bureau of Reclamation, Environmental Protection Agency (EPA), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2017 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Funding for the State Criminal Alien Assistance Program Victims of Crime Act Funding SCAAP Reauthorization (S745) SCAAP Appropriations Transfer Authority Cannabis Legislation (HR 331; HR 714; HR 715; 975; HR 1227; HR 1810; HR 1823; HR 1824; HR 1841; S 776; S 777; S 780)
Client expense: Not reported · Firm income: $30,000
Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Indian Affairs (BIA), Bureau of Justice Assistance, Environmental Protection Agency (EPA), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Justice, Dept of (DOJ), SENATE
2017 · fourth_quarter · Health Issues
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 S.780, Responsibly Addressing the Marijuana Policy Gap Act of 2017 S.1276, Cannabidiol Research Expansion Act S.2004, Combating the Opioid Epidemic Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2017 · fourth_quarter · Alcohol and Drug Abuse
H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation H.R. 3374 Drunk Driving H.R. 3534 State Legalized Marijuana S. 1553 Schedule 1 Controlled Substances S. 1554 Controlled Substance Continuing Education S. 1689 Controlled Substances Act H.R. 3964 Registration Requirements for Prescribers of Opioids H.R. 4482 Opioid Abuse and Addiction S. 2008 Opioid Epidemic and Drug Sample Backlogs
Client expense: $1,390,000 · Firm income: Not reported
2017 · third_quarter · Law Enforcement/Crime/Criminal Justice
Funding for the State Criminal Alien Assistance Program (SCAAP); the Community Oriented Policing Services (COPS) program; and the Byrne/JAG program SCAAP Reauthorization (S 745) Cannabis Legislation (HR 331; HR 714; HR 715; 975; HR 1227; HR 1810; HR 1823; HR 1824; HR 1841; S 776; S 777; S 780)
Client expense: Not reported · Firm income: $20,000
Government targets: Army, Dept of (Corps of Engineers), Bureau of Justice Assistance, Bureau of Reclamation, Environmental Protection Agency (EPA), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2017 · third_quarter · Law Enforcement/Crime/Criminal Justice
Funding for the State Criminal Alien Assistance Program Victims of Crime Act Funding SCAAP Reauthorization (S745) SCAAP Appropriations Transfer Authority Cannabis Legislation (HR 331; HR 714; HR 715; 975; HR 1227; HR 1810; HR 1823; HR 1824; HR 1841; S 776; S 777; S 780)
Client expense: Not reported · Firm income: $30,000
Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Indian Affairs (BIA), Bureau of Justice Assistance, Environmental Protection Agency (EPA), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Justice, Dept of (DOJ), SENATE
2017 · third_quarter · Health Issues
H.R.3358/S.1771, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations, FY2018, provisions relating to NIH and drug abuse and treatment Drug abuse research and treatment related issues: H.R.1732, Synthetic Drug Control Act of 2017 H.R.2851/S.1327, Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 (SITSA) H.R.3391, Medical Marijuana Research Act of 2017 S.780, Responsibly Addressing the Marijuana Policy Gap Act of 2017 S.1276, Cannabidiol Research Expansion Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2017 · third_quarter · Alcohol and Drug Abuse
H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation H.R. 3374 Drunk Driving H.R. 3534 State Legalized Marijuana S. 1553 Schedule 1 Controlled Substances S. 1554 Controlled Substance Continuing Education S. 1689 Controlled Substances Act
Client expense: $1,250,000 · Firm income: Not reported
2017 · first_quarter · Law Enforcement/Crime/Criminal Justice
Funding for the State Criminal Alien Assistance Program (SCAAP); the Community Oriented Policing Services (COPS) program; and the Byrne/JAG program SCAAP Reauthorization (S 745) Cannabis Legislation (HR 331; HR 714; HR 715; 975; HR 1227; HR 1810; HR 1823; HR 1824; HR 1841; S 776; S 777; S 780)
Client expense: Not reported · Firm income: $20,000
Government targets: Army, Dept of (Corps of Engineers), Bureau of Justice Assistance, Bureau of Reclamation, Environmental Protection Agency (EPA), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2017 · first_quarter · Law Enforcement/Crime/Criminal Justice
Funding for the State Criminal Alien Assistance Program Victims of Crime Act Funding SCAAP Reauthorization (S745) SCAAP Appropriations Transfer Authority Cannabis Legislation (HR 331; HR 714; HR 715; 975; HR 1227; HR 1810; HR 1823; HR 1824; HR 1841; S 776; S 777; S 780)
Client expense: Not reported · Firm income: $30,000
Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Indian Affairs (BIA), Bureau of Justice Assistance, Environmental Protection Agency (EPA), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Justice, Dept of (DOJ), SENATE
2017 · second_quarter · Alcohol and Drug Abuse
H.R. 714 Use of Medicinal Marihuana H.R. 715 Rescheduling of Marihuana H.R. 975 Controlled Substances Act Application to Marihuana H.R. 1781 Synthetic Opioids H.R. 1824 Federal and State Marijuana Policy Gap Reduction S. 581 Opioids Addiction Information in Medical Records S. 780 Federal and State Marijuana Policy Gap Reduction H.R. 2020 Rescheduling of Marijuana H.R. 2063 Opioid Dispensary Registration Training Condition S. 1078 FDA Opioid Approval Procedures S. 1079 FDA Opioid Approval and Revocation S. 1327 Controlled Substance Analogues Regulation
Client expense: $1,460,000 · Firm income: Not reported
2017 · second_quarter · Law Enforcement/Crime/Criminal Justice
Funding for the State Criminal Alien Assistance Program (SCAAP); the Community Oriented Policing Services (COPS) program; and the Byrne/JAG program SCAAP Reauthorization (S 745) Cannabis Legislation (HR 331; HR 714; HR 715; 975; HR 1227; HR 1810; HR 1823; HR 1824; HR 1841; S 776; S 777; S 780)
Client expense: Not reported · Firm income: $20,000
Government targets: Army, Dept of (Corps of Engineers), Bureau of Justice Assistance, Bureau of Reclamation, Environmental Protection Agency (EPA), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2017 · second_quarter · Law Enforcement/Crime/Criminal Justice
Funding for the State Criminal Alien Assistance Program Victims of Crime Act Funding SCAAP Reauthorization (S745) SCAAP Appropriations Transfer Authority Cannabis Legislation (HR 331; HR 714; HR 715; 975; HR 1227; HR 1810; HR 1823; HR 1824; HR 1841; S 776; S 777; S 780)
Client expense: Not reported · Firm income: $30,000
Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Indian Affairs (BIA), Bureau of Justice Assistance, Environmental Protection Agency (EPA), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Justice, Dept of (DOJ), SENATE
2017 · first_quarter · Law Enforcement/Crime/Criminal Justice
Funding for the State Criminal Alien Assistance Program (SCAAP); the Community Oriented Policing Services (COPS) program; and the Byrne/JAG program SCAAP Reauthorization (S 745) Cannabis Legislation (HR 331; HR 714; HR 715; 975; HR 1227; HR 1810; HR 1823; HR 1824; HR 1841; S 776; S 777; S 780)
Client expense: Not reported · Firm income: $20,000
Government targets: Army, Dept of (Corps of Engineers), Bureau of Justice Assistance, Bureau of Reclamation, Environmental Protection Agency (EPA), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2017 · first_quarter · Law Enforcement/Crime/Criminal Justice
Funding for the State Criminal Alien Assistance Program Victims of Crime Act Funding SCAAP Reauthorization (S745) SCAAP Appropriations Transfer Authority Cannabis Legislation (HR 331; HR 714; HR 715; 975; HR 1227; HR 1810; HR 1823; HR 1824; HR 1841; S 776; S 777; S 780)
Client expense: Not reported · Firm income: $30,000
Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Indian Affairs (BIA), Bureau of Justice Assistance, Environmental Protection Agency (EPA), Federal Housing Finance Agency (FHFA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Justice, Dept of (DOJ), SENATE
| HR 1824 |
115th |
| Related bill |
| HR 1820 | 115th | Related bill |
| HR 1810 | 115th | Related bill |
Government targets: Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), Natl Security Council (NSC), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
Government targets: HOUSE OF REPRESENTATIVES, SENATE